The concern about ACE/ARB and COVID-19: Time to hold your horses!

Concern about coronavirus 2019 (COVID-19) morbidity and mortality has drawn attention to the potential role of angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) because the SARS-CoV-2 uses the ACE2 receptor as its point of entry into the body. It is not clear if...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Am Pharm Assoc (2003)
Autores principales: Pergolizzi, Joseph V., Varrassi, Giustino, Magnusson, Peter, LeQuang, Jo Ann, Leopoulou, Marianna, Paladini, Antonella, Taylor, Robert, Wollmuth, Charles, Breve, Frank
Formato: Artigo
Lenguaje:Inglês
Publicado: Published by Elsevier Inc. on behalf of the American Pharmacists Association. 2020
Materias:
Science and Practice
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7837157/
https://ncbi.nlm.nih.gov/pubmed/32747165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.japh.2020.06.026
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares